Aptorum Group Limited (NASDAQ:APM) Short Interest Update

Aptorum Group Limited (NASDAQ:APM) was the target of a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 184,800 shares, an increase of 1,564.9% from the December 15th total of 11,100 shares. Currently, 4.7% of the company’s stock are short sold. Based on an average daily volume of 2,190,000 shares, the days-to-cover ratio is presently 0.1 days.

Aptorum Group Trading Down 5.8 %

Shares of Aptorum Group stock traded down $0.08 on Monday, hitting $1.31. 114,837 shares of the company traded hands, compared to its average volume of 2,597,329. Aptorum Group has a 12-month low of $0.46 and a 12-month high of $17.49. The company has a 50-day moving average price of $1.07 and a 200 day moving average price of $2.18.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.